ABG Sundal Collier Begins Camurus Coverage at Buy
Idag, 14:40
Idag, 14:40
08:40 AM EDT, 04/20/2026 (MT Newswires) -- ABG Sundal Collier on Monday initiated its coverage of biopharmaceutical company Camurus (CAMX.ST) with a buy rating and a price target of 750 kronor.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Idag, 14:40
08:40 AM EDT, 04/20/2026 (MT Newswires) -- ABG Sundal Collier on Monday initiated its coverage of biopharmaceutical company Camurus (CAMX.ST) with a buy rating and a price target of 750 kronor.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Banker
Analys
Banker
Analys
1 DAG %
Senast
OMX Stockholm 30
−0,87%
(16:29)
OMX Stockholm 30
1 DAG %
Senast
3 154,36